Platelet-rich plasma: new clinical application: a pilot study for treatment of jumper's knee.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 19380129.
- Also identified by DOI 10.1016/j.injury.2008.11.026.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study describes a simple, low-cost, minimally invasive way to apply PRP growth factors to chronic patellar tendinosis; 20 male athletes with a mean history of 20.7 months of pain received treatment, and outcomes were prospectively evaluated at 6 months follow-up. No severe adverse events were observed, and statistically significant improvements in all scores were recorded. The results suggest that this method may be safely used for the treatment of jumper's knee, by aiding the regeneration of tissue which otherwise has low healing potential.
Medical subject headings
- Athletic Injuries
- Intercellular Signaling Peptides and Proteins
- Platelet-Rich Plasma
- Tendinopathy